authors
- Knox, JJ
- Chen, XE
- Feld, R
- Nematollahi, M
- Cheiken, R
- Pond, Gregory
- Zwiebel, JA
- Gill, S
- Moore, M
A phase I–II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798)
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2008
has subject area
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Adult (MeSH)
- Aged (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Carcinoma, Hepatocellular (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Doxorubicin (MeSH)
- Female (MeSH)
- Hematologic Diseases (MeSH)
- Humans (MeSH)
- Liver Neoplasms (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Proto-Oncogene Proteins c-bcl-2 (MeSH)
- Thionucleotides (MeSH)
- Treatment Outcome (MeSH)
published in
- Investigational New Drugs Journal